Apollo Therapeutics gathers $145m

Apollo Therapeutics, a biopharmaceutical company, has raised $145 million in financing.

Apollo Therapeutics, a biopharmaceutical company, has raised $145 million in financing. Patient Square Capital led the round with participation from other backers that include Rock Springs Capital, Reimagined Ventures and UCL Technology Fund.

Source: Press Release